Loading the security page…
A security analysis is not yet prepared for this market.
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
Prelude Therapeutics Incorporated (PRLD) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Prelude Therapeutics Incorporated (PRLD) on November 13, 2026 is $3.45, −1.99% on the day. Over 52 weeks the stock traded between $1.29 and $6.83; the price now sits 39% of the way up that range. Over the past year the price changed by +128.48%. Market capitalisation is $339.44 million, rank 173 among 382 stocks of the same industry with a known capitalisation.
Prelude Therapeutics Incorporated trades on Nasdaq under the ticker PRLD. The company belongs to the Health care sector. The trading history on this page starts on 25 September 2020.
Over the past 52 weeks PRLD has traded between $1.30 and $6.83. As of 13 November 2026 the price stood 38.93% of the way from the 52-week low to the high.
Over one year PRLD shares rose 128.48%; over six months they fell 22.99%. Volatility over 90 days is 80.76%. Dividends are not included: this is price change only, as of 13 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 15.1, above the sector median of 3.7. Price to book is 2.5, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
Prelude Therapeutics Incorporated reported revenue of $22M and a net loss of $60M over the last four quarters. Net margin is −269.75%. Earnings per share are −$0.73. Market capitalisation is $339M.
PRLD has a return on equity of −45.23%, below the sector median of −40.58%. Return on assets is −31.94%, below the sector median of −30.08%. Operating margin is −300.56%, below the sector median of −20.96%.